Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kurbatova, A. Bajard, H. Tiddens, V. Volpert, C. Cornu, N. Bessonov, B. Kassai, S. Chabaud, P. Nony, D. Caudri (Lyon, Bron, France; Rotterdam, Netherlands). Modelling and simulation of experimental designs to find the best design of randomized clinical trials in a rare disease: Cystic fibrosis. Eur Respir J 2014; 44: Suppl. 58, 1220

Member's Comments

No comment yet.

Related content which might interest you: Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017 Year: 2017 Cystic Fibrosis Lung disease, from animal models to experimental therapeutics. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Cystic fibrosis: paediatric Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Cystic fibrosis: paediatric Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Cystic fibrosis: paediatric Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Cystic fibrosis: paediatric Source: ERS Skills Course 2016 Year: 2016 Difficulties in optimizing vitamin D levels in paediatric cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 A new gold standard for assessing CT in early CF lung disease? Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Clinical outcomes of bilateral lung transplantation for cystic fibrosis in frame of the european multicentric COLT study Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 The role of CFTR/ENaC genotype in cystic fibrosis-like phenotypes Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014 Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Lung MRI findings in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007 The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Two-compartment model of gas mixing in patients with asthma and cystic fibrosis Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013